Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains high and additional therapeutic strategies should be evaluated. The objective of this study was to evaluate the cholesterol-lowering efficacy and mechanism of action of bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 capsules in hypercholesterolemic adults.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur J Clin Nutr

Title: European journal of clinical nutrition

ISSN (Electronic): 1476-5640

ISSN (Print): 0954-3007

Publication date (Electronic): Nov 2012

Volume: 66

Issue: 11

Affiliations

[1 ] Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Article

Publisher Item ID: ejcn2012126

DOI: 10.1038/ejcn.2012.126

PubMed ID: 22990854

SO-VID: 60b65829-864a-47ca-920b-675151620713

History

Data availability:

Comments

Comment on this article

scite_

Cited by 85

See all cited by